Press Releases
These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
May 9, 2023Retrospective cohort study presented at ISPOR analyzed real-world data of users and non-users of a digital health solution NEW YORK, May 9, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO)...
- May 4, 2023
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital health market, today announced that it would release its financial results for the first quarter ended March 31, 2023, on Thursday,...
- May 2, 2023
Newly designated convertible preferred stock priced at the market under Nasdaq rules with significant participation by select members of leadership, the Board and existing investors Company also...
- Apr 4, 2023
Dario also appoints digital veteran, Arnaud Robert, to the role of Strategic Advisor to the Chief Executive Officer The appointments strengthen Dario's ability to scale its digital therapeutics...
- Mar 27, 2023
New agreement is the first contract resulting from strategic partnership with Sanofi NEW YORK, March 27, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader...
- Mar 22, 2023
New agreement integrates Dario's cardiometabolic suite into Amwell's market leading digital care delivery enablement platform covering over 90 million lives NEW YORK, March 22, 2023 /PRNewswire/...
- Mar 14, 2023
Dario's musculoskeletal solution uses data from a biofeedback sensor to drive healthier behaviors and reduce pain NEW YORK, March 14, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO)(the...
- Mar 9, 2023
Continued to improve the financial profile of the Company Full-year 2022 revenue of $27.7 million increased 34.8% over $20.5 million in 2021, as B2B revenue growth more than offset managed...
- Mar 2, 2023
DarioHealth Corp. (NASDAQ: DRIO), a leader in the global digital therapeutics (DTx) market, today announced it would release its financial results for the fourth quarter and year ended December...
- Feb 27, 2023
Dario demonstrates the impact of targeted coaching interventions in a digital-first chronic care solution Dario solution demonstrates significant impact on hypoglycemic events in senior...